See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Presenter: Peter Smits

October 23, 2012

Presentation TCT 2012

TCT-2. Peri-procedural Outcomes After Carotid Artery Stenting with the First 15,000 Patients Enrolled in the SAPPHIRE Worldwide Study

Presenter: D. Christopher Metzger

October 23, 2012

Presentation TCT 2012

Early Cellular Interaction and Biomaterials: Bioabsorbable Polymers and Advanced Metallic Surfaces Are the Next Logical Step!

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

Yes: The Quantitative Threshold Should Be Lowered!

Presenter: Maurice Sarano

October 23, 2012

Presentation TCT 2012

TCT-96. Influence of Gender on Clinical Outcomes Following Transcatheter Aortic Valve Implantation: Results from the UK TAVI Registry on Behalf of the UK TAVI Steering Group...

Presenter: Rasha Al-Lamee

October 23, 2012

Presentation TCT 2012

TCT-53. Assessment of 30-day Rehospitalization for Acute Myocardial Infarction in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention: A...

Presenter: Jay Bae

October 23, 2012

Presentation TCT 2012

Circulatory Support for Cardiogenic Shock

Presenter: E. Magnus Ohman

October 23, 2012

Presentation TCT 2012

Introduction(9)

Presenter: Karthik Ananthasubramaniam

October 23, 2012

Presentation TCT 2012

Preclinical Review: Experimental Models and Biological Considerations for the Validation of Heart Failure Devices

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

Presenter: Issam Mikati

October 23, 2012

Advertisement

Slides

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

TCT-2. Peri-procedural Outcomes After Carotid Artery Stenting with the First 15,000 Patients Enrolled in the SAPPHIRE Worldwide Study

Early Cellular Interaction and Biomaterials: Bioabsorbable Polymers and Advanced Metallic Surfaces Are the Next Logical Step!

Yes: The Quantitative Threshold Should Be Lowered!

TCT-96. Influence of Gender on Clinical Outcomes Following Transcatheter Aortic Valve Implantation: Results from the UK TAVI Registry on Behalf of the UK TAVI Steering Group...

TCT-53. Assessment of 30-day Rehospitalization for Acute Myocardial Infarction in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention: A...

Circulatory Support for Cardiogenic Shock

Introduction(9)

Preclinical Review: Experimental Models and Biological Considerations for the Validation of Heart Failure Devices

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content